THU070 Randomized, Placebo-controlled Phase 3 Trial Protocol Assessing The Efficacy And Safety Of Octreotide Subcutaneous Depot (CAM2029) In Patients With Acromegaly
Ontology highlight
SUBMITTER:
PROVIDER: S-EPMC10554032 | biostudies-literature | 2023 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA